Optec International Quick Ratio (GRMD) starting from the second quarter 2018 to second quarter 2017, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Optec International, Inc.  (GRMD)

Optec International's Quick Ratio

GRMD's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2018, Quick Ratio fell to 0 a new company low.

Within Major Pharmaceutical Preparations industry 470 other companies have achieved higher Quick Ratio than Optec International in second quarter 2018. While Quick Ratio total ranking has improved so far during the Q2 2018 to 5209, from total ranking in the first quarter 2018 at 5271.

Explain Quick Ratio?
How much Cash & cash equivalents GRMD´s has?
What are GRMD´s Current Liabilities?




GRMD Quick Ratio (Dec 31 2018)
Q2
(Sep 30 2018)
Q1
(Jun 30 2018)
Q4
(Mar 31 2018)
Q3
(Dec 31 2017)
Q2
Y / Y Current Liabilities Change 862.96 % 4465.16 % 25172.86 % 14378.57 % -
Y / Y Cash & cash equivalent Change 360.67 % 1086.98 % 8905.56 % -63.98 % 90.68 %
Quick Ratio MRQ 0 0.01 0.02 0 0
GRMD's Total Ranking # 5209 # 5271 # 4308 # 5223 # 5156
Seq. Current Liabilities Change 76.23 % 77.88 % 74.55 % 75.99 % 735.45 %
Seq. Cash & cash equivalent Change -70.44 % 1.51 % 4231.79 % -64.56 % -23.84 %



Quick Ratio second quarter 2018 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 471
Healthcare Sector # 912
Overall Market # 5209


Quick Ratio Statistics
High Average Low
94.58 11.63 0
(Sep 30 2015)   (Mar 31 2018)




Financial Statements
Optec International's Current Liabilities $ 6 Millions Visit GRMD's Balance sheet
Optec International's Cash & cash equivalent $ 0 Millions Visit GRMD's Balance sheet
Source of GRMD's Sales Visit GRMD's Sales by Geography


Cumulative Optec International's Quick Ratio

GRMD's Quick Ratio for the trailling 12 Months

GRMD Quick Ratio

(Dec 31 2018)
12 Months
(Sep 30 2018)
12 Months
(Jun 30 2018)
12 Months
(Mar 31 2018)
12 Months
(Dec 31 2017)
12 Months
Y / Y Current Liabilities TTM Growth 1641.75 % 7744.16 % 15841.55 % 8440.17 % 5170.66 %
Y / Y Cash & cash equivalent TTM Growth 935.31 % 979.32 % 428.35 % -63.22 % -71.27 %
Quick Ratio TTM 0.01 0.01 0.01 0 0.01
Total Ranking TTM # 5140 # 5157 # 4797 # 5176 # 4711
Seq. Current Liabilities TTM Growth 76.39 % 89.8 % 105.81 % 152.77 % 694.42 %
Seq. Cash & cash equivalent TTM Growth 11.17 % 79.2 % 534.99 % -18.16 % 15.89 %


On the trailing twelve months basis In Spite of the jump in Current Liabilities in the Q2 2018 to $5.55 millions, cumulative Quick Ratio remained unchanged at 0.01 below the Optec International, Inc. average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 438 other companies have achieved higher Quick Ratio than Optec International. While Quick Ratio overall ranking has improved so far to 5140, from total ranking during the twelve months ending first quarter 2018 at 5157.

Explain Quick Ratio?
How much Cash & cash equivalents GRMD´s has?
What are GRMD´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 439
Healthcare Sector # 863
Within the Market # 5140


trailing twelve months Quick Ratio Statistics
High Average Low
0.04 0.01 0
(Jun 30 2015)   (Mar 31 2018)




Companies with similar Quick Ratio in the quarter ending Dec 31 2018, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2018 MRQ Cash & cash equivalentDec 31 2018 MRQ Current Liabilities
Gt Biopharma Inc 0.00 $ 0.060  Millions$ 14.029  Millions
Integrated Biopharma Inc 0.00 $ 0.045  Millions$ 15.511  Millions
Nanomix Corp 0.00 $ 0.012  Millions$ 4.659  Millions
Oncotelic Therapeutics Inc 0.00 $ 0.003  Millions$ 1.134  Millions
Optec International, Inc. 0.00 $ 0.009  Millions$ 5.546  Millions
Theralink Technologies Inc 0.00 $ 0.007  Millions$ 7.774  Millions
Biostax Corp 0.00 $ 0.006  Millions$ 11.342  Millions
Skinvisible Inc 0.00 $ 0.002  Millions$ 4.940  Millions

Date modified: 2026-06-22T16:30:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.